UK markets closed

Biocartis Group NV (BCART.BR)

Brussels - Brussels Delayed price. Currency in EUR
Add to watchlist
3.01000.0000 (0.00%)
At close: 05:35PM CET
Currency in EUR

Valuation measures4

Market cap (intra-day) 212.34M
Enterprise value 278.05M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)4.36
Price/book (mrq)N/A
Enterprise value/revenue 5.76
Enterprise value/EBITDA -5.61

Trading information

Stock price history

Beta (5Y monthly) 1.67
52-week change 3-33.70%
S&P500 52-week change 316.15%
52-week high 34.9000
52-week low 32.8150
50-day moving average 33.5763
200-day moving average 33.8959

Share statistics

Avg vol (3-month) 366.7k
Avg vol (10-day) 3179.02k
Shares outstanding 557.55M
Implied shares outstanding 6N/A
Float 852.08M
% held by insiders 113.63%
% held by institutions 122.33%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2020
Most-recent quarter (mrq)30 Jun 2021

Profitability

Profit margin -112.53%
Operating margin (ttm)-85.05%

Management effectiveness

Return on assets (ttm)-16.08%
Return on equity (ttm)-258.68%

Income statement

Revenue (ttm)61.01M
Revenue per share (ttm)1.07
Quarterly revenue growth (yoy)31.00%
Gross profit (ttm)-14.81M
EBITDA -47.68M
Net income avi to common (ttm)-68.65M
Diluted EPS (ttm)-1.2040
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)84.91M
Total cash per share (mrq)1.48
Total debt (mrq)149.41M
Total debt/equity (mrq)N/A
Current ratio (mrq)4.40
Book value per share (mrq)-0.00

Cash flow statement

Operating cash flow (ttm)-48.49M
Levered free cash flow (ttm)-27.72M